Hancock Whitney Corp Enanta Pharmaceuticals Inc Transaction History

Hancock Whitney Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$43.76 - $53.11 $252,101 - $305,966	-5,761 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$41.69 - $54.95 $240,176 - $316,566	5,761 New	5,761 $284,000
Q4 2020 Feb 09, 2021	SELL	$41.16 - $47.47 $204,935 - $236,353	-4,979 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$43.36 - $53.53 $1,084 - $1,338	-25 Reduced 0.5%	4,979 $228,000
Q2 2020 Jul 30, 2020	BUY	$46.37 - $57.58 $232,035 - $288,130	5,004 New	5,004 $251,000

111

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $103M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.